Expertise in
8
conditions

Matthias Boentert

UKM Marienhospital Steinfurt
Steinfurt, NW, DE 
Expertise in
8
conditions
UKM Marienhospital Steinfurt
Steinfurt, NW, DE 

Overview

Matthias Boentert practices practicing medicine in Steinfurt, Germany.

Mr. Boentert is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Cramp-Fasciculation Syndrome.

He is actively involved in clinical research, co-authoring 122 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

UKM Marienhospital Steinfurt
Steinfurt, NW 48565, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Participants With Post-Polio Syndrome
A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Participants With Post-Polio Syndrome
Enrollment Status: Terminated
Publish Date: December 05, 2025
Intervention Type: Biological, Drug
Study Drug: Flebogamma
Study Phase: Phase 2/Phase 3
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Unknown
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
View 1 Less Clinical Trial

122 Total Publications

ALS motor phenotypes: a revised 'OPM' classification.
ALS motor phenotypes: a revised 'OPM' classification.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: March 17, 2026

Frequently Asked Questions about Matthias Boentert

Is Matthias Boentert a top-rated expert for Pompe Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Matthias Boentert is classified as an Distinguished expert for Pompe Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Matthias Boentert participate in research or clinical trials?

Yes. Matthias Boentert has published 122 articles and abstracts on conditions like Pompe Disease. You can view a list of Matthias Boentert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Boentert's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile